- The Dish’s Weekly Biotechnology News Wrap Up – April 21, 2017Posted 4 days ago
- Glycosylation Overview and How to Control Glycosylation using In Vitro GlycoengineeringPosted 5 days ago
- A Novel Approach for Expansion of High Quality Mesenchymal Stem CellsPosted 6 days ago
- Cell Therapy Clinical Trials: Navigating the operational shift from Phase 1 to Phase 2Posted 1 week ago
- The Dish’s Weekly Biotechnology News Wrap Up – April 14, 2017Posted 2 weeks ago
- GMP Proteins for Cell Therapy Manufacturing: Top 6 Things to KnowPosted 2 weeks ago
- Smart Cell Culture Monitoring – Transforming the way we look at cells in culturePosted 2 weeks ago
- A Primer on Primary Cells and CulturePosted 2 weeks ago
- The Importance of Resin Selection in Development of a Platform Bioprocess FilmPosted 2 weeks ago
- The Dish’s Weekly Biotechnology News Wrap Up – April 7, 2017Posted 3 weeks ago
This week’s headlines include: In a Dragon’s Blood, Scientists Discover a Potential Antibiotic, Novartis advances with...
Introduction Glycosylation is the most common type of post translational protein modification. It is also an...
A Guest Blog by Iris Flores, Business Development Manager, StemBioSys, Inc. Human mesenchymal stem cells (hMSCs)...
Can Biogenerics Deliver on the Multibillion-Dollar Market Promise?
Biogenerics have received a lot of publicity regarding the estimated multibillion-dollar market they represent and the discussion has the attention of several companies not involved in the health care...
- Posted 5 July, 2011
The Evolution of Monoclonal Antibodies
Most of us have had to take medicine at some point in our lives, but very few of us ever stop to think about where our medicine comes from...
- Posted 28 June, 2011
Stem Cell Therapy for Type 1 Diabetes is on the Horizon
ViaCyte, a stem cell company in San Diego, is offering hope for many patients with Type 1 Diabetes. Type 1 Diabetes is caused by a lack of functioning islet...
- Posted 22 June, 2011
The Need for Defined, Animal-Free, Components in Vaccine Production Media
Many vaccines currently given to humans are produced using animal products. This includes the use of media formulations supplemented with bovine serum. The use of animal products in vaccine...
- Posted 20 June, 2011
The Future of Biogenerics
In March 2010, when President Obama signed into law the Affordable Care Act he cleared the way for the Food and Drug Administration (FDA) to approve biogenerics. Before this...
- 14 June, 2011